These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 24251783

  • 1. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
    Sprinzl MF, Russo C, Kittner J, Allgayer S, Grambihler A, Bartsch B, Weinmann A, Galle PR, Schuchmann M, Protzer U, Bauer T.
    J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
    [Abstract] [Full Text] [Related]

  • 2. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C, Laccabue D, Lampertico P, Giuberti T, Viganò M, Schivazappa S, Alfieri A, Pesci M, Gaeta GB, Brancaccio G, Colombo M, Missale G, Ferrari C.
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 4. Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B.
    Chen Y, Li X, Ye B, Yang X, Wu W, Chen B, Pan X, Cao H, Li L.
    Antiviral Res; 2011 Jul; 91(1):23-31. PubMed ID: 21549152
    [Abstract] [Full Text] [Related]

  • 5. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P, Artsen A, Niesters HG, Osterhaus AD, Pontesilli O.
    J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
    [Abstract] [Full Text] [Related]

  • 6. [The impact of antiviral therapy on virus-specific T-cell reactivity in patients with chronic hepatitis B].
    Feng X, Yan HP, Liao HY, Liu YM, Huang YL, Zhang GY, Lin F, Zhang X, Zhao Y, Zhang HP, Wang S, Wang Y.
    Zhonghua Yi Xue Za Zhi; 2012 Mar 20; 92(11):739-42. PubMed ID: 22781352
    [Abstract] [Full Text] [Related]

  • 7. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M, Sun X, Zhou Z, Zhang X, Jin S, Gao Y, Gao Y.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb 20; 32(2):240-4. PubMed ID: 26927386
    [Abstract] [Full Text] [Related]

  • 8. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C, Janssen HLA, Rossi M, Yoon SK, Vecchi A, Barili V, Yoshida EM, Trinh H, Rodell TC, Laccabue D, Alfieri A, Brillo F, Fisicaro P, Acerbi G, Pedrazzi G, Andreone P, Cursaro C, Margotti M, Santoro R, Piazzolla V, Brunetto MR, Coco B, Cavallone D, Zhao Y, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Massetto B, Fung S, Ahn SH, Ma X, Mangia A, Ferrari C.
    Gastroenterology; 2019 Jul 20; 157(1):227-241.e7. PubMed ID: 30930022
    [Abstract] [Full Text] [Related]

  • 9. Peginterferon-α does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis.
    Penna A, Laccabue D, Libri I, Giuberti T, Schivazappa S, Alfieri A, Mori C, Canetti D, Lampertico P, Viganò M, Colombo M, Loggi E, Missale G, Ferrari C.
    J Hepatol; 2012 Jun 20; 56(6):1239-46. PubMed ID: 22326467
    [Abstract] [Full Text] [Related]

  • 10. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z, Kong X, Li F, Wei H, Sun R, Tian Z.
    J Immunol; 2013 Oct 15; 191(8):4184-93. PubMed ID: 24048897
    [Abstract] [Full Text] [Related]

  • 11. HBcAg-specific IL-21-producing CD4+ T cells are associated with relative viral control in patients with chronic hepatitis B.
    Li L, Liu M, Cheng LW, Gao XY, Fu JJ, Kong G, Feng X, Pan XC.
    Scand J Immunol; 2013 Nov 15; 78(5):439-46. PubMed ID: 23957859
    [Abstract] [Full Text] [Related]

  • 12. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
    Tang TJ, de Man RA, Kusters JG, Kwekkeboom J, Hop WC, van der Molen RG, Schalm SW, Janssen HL.
    J Med Virol; 2004 Feb 15; 72(2):215-22. PubMed ID: 14695662
    [Abstract] [Full Text] [Related]

  • 13. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.
    Cao W, Qiu Z, Zhu T, Li Y, Han Y, Li T.
    J Clin Virol; 2014 Sep 15; 61(1):40-6. PubMed ID: 25049205
    [Abstract] [Full Text] [Related]

  • 14. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C.
    Gut; 2009 Jul 15; 58(7):974-82. PubMed ID: 19201769
    [Abstract] [Full Text] [Related]

  • 15. Impact of early viral kinetics on T-cell reactivity during antiviral therapy in chronic hepatitis B.
    Lau GK, Cooksley H, Ribeiro RM, Powers KA, Shudo E, Bowden S, Hui CK, Anderson J, Sorbel J, Mondou E, Rousseau F, Lewin S, Perelson AS, Locornini S, Naoumov NV.
    Antivir Ther; 2007 Jul 15; 12(5):705-18. PubMed ID: 17713154
    [Abstract] [Full Text] [Related]

  • 16. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, Furutani M, Yamasaki T, Korenaga K, Yamashita S, Konishi T, Okita K.
    J Med Virol; 2003 Nov 15; 71(3):376-84. PubMed ID: 12966542
    [Abstract] [Full Text] [Related]

  • 17. Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    Bruder Costa J, Dufeu-Duchesne T, Leroy V, Bertucci I, Bouvier-Alias M, Pouget N, Brevot-Lutton O, Bourliere M, Zoulim F, Plumas J, Aspord C, ANRS HB06 PEGAN study group.
    PLoS One; 2016 Nov 15; 11(6):e0158297. PubMed ID: 27348813
    [Abstract] [Full Text] [Related]

  • 18. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, Lewin SR.
    J Virol; 2005 Mar 15; 79(5):3038-51. PubMed ID: 15709024
    [Abstract] [Full Text] [Related]

  • 19. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard MJ, Zoulim F, Plumas J, Aspord C.
    Hepatology; 2012 Nov 15; 56(5):1706-18. PubMed ID: 22707082
    [Abstract] [Full Text] [Related]

  • 20. Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients.
    Pang X, Zhang L, Liu N, Liu B, Chen Z, Li H, Chen M, Peng M, Ren H, Hu P.
    Clin Exp Immunol; 2020 Oct 15; 202(1):80-92. PubMed ID: 32638357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.